David R Rubinow Selected Research

Postpartum Depression (Post-Natal Depression)

1/2022	Transcriptome-wide association study for postpartum depression implicates altered B-cell activation and insulin resistance.
1/2020	Transdermal estradiol for postpartum depression: results from a pilot randomized, double-blind, placebo-controlled study.
1/2019	Brexanolone injection for post-partum depression treatment - Authors' reply.
1/2018	Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials.
1/2017	Open-label, proof-of-concept study of brexanolone in the treatment of severe postpartum depression.
1/2017	HPA axis reactivity to pharmacologic and psychological stressors in euthymic women with histories of postpartum versus major depression.
1/2016	Reproductive Steroid Regulation of Mood and Behavior.
1/2016	History of postpartum depression in a clinic-based sample of women with premenstrual dysphoric disorder.
2/2015	The role of reproductive hormones in postpartum depression.
9/2014	Allopregnanolone as a mediator of affective switching in reproductive mood disorders.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David R Rubinow Research Topics

Disease

16	Premenstrual Dysphoric Disorder 11/2021 - 11/2002
14	Mood Disorders (Mood Disorder) 01/2018 - 06/2002
13	Postpartum Depression (Post-Natal Depression) 01/2022 - 05/2003
6	Mental Disorders (Mental Disorder) 01/2018 - 10/2004
6	Premenstrual Syndrome (Premenstrual Tension) 10/2017 - 07/2003
6	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2016 - 04/2006
4	Major Depressive Disorder (Major Depressive Disorders) 01/2022 - 11/2005
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 04/2011
3	Insulin Resistance 01/2021 - 01/2020
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2020 - 01/2020
2	Sleepiness 01/2019 - 01/2018
2	Dizziness (Lightheadedness) 01/2019 - 01/2018
2	Headache (Headaches) 01/2019 - 01/2018
2	Bipolar Disorder (Manic Depressive Psychosis) 01/2018 - 11/2005
2	Schizophrenia (Dementia Praecox) 01/2018 - 11/2005
2	Wounds and Injuries (Trauma) 01/2017 - 10/2011
2	Heart Diseases (Heart Disease) 06/2011 - 04/2011
1	Nausea 01/2019
1	Hypersensitivity (Allergy) 01/2018
1	Psychotic Disorders (Schizoaffective Disorder) 01/2018
1	Renal Insufficiency (Renal Failure) 01/2018
1	Anxiety Disorders (Anxiety Disorder) 01/2016
1	Primary Ovarian Insufficiency 09/2014
1	Migraine Disorders (Migraine) 10/2013
1	Anhedonia 07/2013
1	Pathologic Complete Response 04/2012
1	Depressive Disorder (Melancholia) 04/2012
1	Inflammation (Inflammations) 10/2011
1	Birth Weight (Birth Weights) 10/2011
1	Breast Neoplasms (Breast Cancer) 07/2010
1	Coronary Artery Disease (Coronary Atherosclerosis) 07/2010
1	Genetic Predisposition to Disease (Genetic Predisposition) 10/2007

Drug/Important Bio-Agent (IBA)

15	SteroidsIBA 01/2021 - 06/2002
11	Progesterone FDA LinkGeneric 12/2018 - 02/2009
11	Hormones (Hormone)IBA 01/2018 - 10/2003
10	Tuberculin (PPD)IBA 01/2022 - 05/2003
10	Estradiol (Delestrogen)FDA LinkGeneric 11/2021 - 02/2009
4	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2020 - 02/2005
4	Pregnanolone (Allopregnanolone)IBA 01/2018 - 09/2014
4	NeurosteroidsIBA 03/2016 - 04/2006
4	Estrogens (Estrogen)FDA Link 07/2013 - 07/2010
3	brexanoloneIBA 01/2019 - 01/2017
3	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2016 - 03/2011
3	Testosterone (Sustanon)FDA Link 09/2014 - 04/2006
2	Leuprolide (Lupron)FDA LinkGeneric 10/2017 - 03/2011
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 06/2012 - 11/2002
2	Fluoxetine (Prozac)FDA LinkGeneric 06/2012 - 11/2002
2	Biological ProductsIBA 04/2008 - 06/2002
2	Estrogen Receptor alphaIBA 10/2007 - 11/2005
1	Chemokine CXCL10IBA 01/2021
1	oxidized low density lipoproteinIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Interleukin-6 (Interleukin 6)IBA 10/2020
1	gamma-Aminobutyric Acid (GABA)IBA 01/2019
1	zuranoloneIBA 01/2019
1	Oxytocin (Pitocin)FDA LinkGeneric 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	Aminobutyrates (Aminobutyric Acid)IBA 01/2018
1	Dutasteride (Avodart)FDA Link 03/2016
1	3,4-methylenedioxyethamphetamine (MDEA)IBA 01/2016
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2016
1	AndrogensIBA 09/2014
1	pyridinium 3-methoxyestra-1,3,5(10)-trien-6-yl sulfate (PMTS)IBA 06/2012
1	Adrenocorticotropic Hormone (ACTH)FDA Link 06/2012
1	Suppositories (Vaginal Suppositories)IBA 06/2012
1	Estrogen ReceptorsIBA 05/2012
1	CytokinesIBA 10/2011
1	mahuang-tangIBA 07/2010
1	Progestins (Progestagens)IBA 07/2010
1	Dihydrotestosterone (Androstanolone)IBA 04/2006
1	PregnenoloneIBA 04/2006
1	Homovanillic AcidIBA 04/2006
1	Dehydroepiandrosterone (DHEA)IBA 04/2006
1	AndrosteroneIBA 04/2006
1	AcidsIBA 04/2006
1	MagnesiumIBA 02/2006
1	Messenger RNA (mRNA)IBA 11/2005
1	Corticotropin-Releasing HormoneIBA 02/2005
1	Anabolic Androgenic SteroidsIBA 10/2004
1	Serotonin AntagonistsIBA 11/2002
1	MetergolineIBA 11/2002
1	Diphenhydramine (Benadryl)FDA LinkGeneric 11/2002

Therapy/Procedure

2	Transcranial Direct Current Stimulation 01/2022 - 01/2019
2	Ambulatory Care (Outpatient Care) 10/2017 - 02/2009
2	Therapeutics 09/2014 - 06/2002
2	Hormone Replacement Therapy (Therapy, Hormone Replacement) 06/2011 - 04/2011
2	Precision Medicine 06/2011 - 04/2011
1	Perinatal Care 11/2009
1	Aftercare (After-Treatment) 11/2002